Nisa Investment Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed 2807
2022
Q4
$0 Sell
4
-12
-75% -$286 ﹤0.01% 2789
2022
Q3
$1K Buy
+16
New +$452 ﹤0.01% 2565

Nisa Investment Advisors's CINC Position: Q1 2023 in Review

Nisa Investment Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 4 shares.

Nisa Investment Advisors first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Nisa Investment Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 4 CinCor Pharma, Inc. Common Stock shares in Q1 2023.
  • Nisa Investment Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Nisa Investment Advisors's CinCor Pharma, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Nisa Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.